Sep 11, 2023 / 06:15PM GMT
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Hi, everybody. Thanks for joining us this afternoon. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley. We're very pleased to be hosting Merck this afternoon. We have Dean Li, who is President of Merck Research Labs; and Caroline Litchfield, who is the company's CFO.
Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Well, thanks both so much for being here today. Really appreciate it. A pleasure to be hosting the company today.
Questions and Answers:
Terence C. Flynn - Morgan Stanley, Research Division - Equity AnalystMaybe Caroline, I thought we'd start off with the business. Obviously, it's been performing exceptionally well here. Maybe just help us think about the